Biomedcode is participating at the BTCure Final meeting 5-7th of February 2017 in Prague


BTCure is an IMI project co-funded by the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The BTCure aims to develop new therapies against rheumatoid arthritis. With a total budget of EUR 35 million and 37 partners from all over Europe, it is hoped that by combining academic and industrial resources, basic understanding of disease processes and therapeutic development will be enhanced.


Return to News